Andreassi Maria Grazia
CNR Institute of Clinical Physiology, G. Pasquinucci Hospital, Via Aurelia Sud-Montepepe 54100, Massa, Italy.
J Mol Med (Berl). 2008 Sep;86(9):1033-43. doi: 10.1007/s00109-008-0358-7. Epub 2008 Jun 19.
Atherosclerosis, an intrinsically age-related disease, is attributed to an excessive inflammatory and fibroproliferative process that selectively affects arteries. However, premature atherosclerosis is a feature of several human diseases that are known to be defective in DNA repair pathways and characterised by predisposition to early onset of age-related diseases. Accordingly, there is a growing amount of data demonstrating that oxidative-stress-induced DNA damage and dysfunctional telomeres play an important role in the pathogenesis of atherosclerosis. This review examines the evidence that an activated DNA response pathway induced by both oxidative DNA damage and telomere dysfunction is the crucial mediator for vascular replicative or premature senescence via activation of the p21cip1 (via p53) and p16ink4 pathways. Prevention of DNA-damage-induced cellular vascular senescence may be a novel target for the clinical treatment of atherosclerosis.
动脉粥样硬化是一种本质上与年龄相关的疾病,归因于选择性影响动脉的过度炎症和纤维增生过程。然而,早发性动脉粥样硬化是几种人类疾病的特征,已知这些疾病存在DNA修复途径缺陷,并以易患早发性年龄相关疾病为特征。因此,越来越多的数据表明,氧化应激诱导的DNA损伤和功能失调的端粒在动脉粥样硬化的发病机制中起重要作用。本综述探讨了以下证据:由氧化DNA损伤和端粒功能障碍诱导的激活的DNA反应途径是通过激活p21cip1(通过p53)和p16ink4途径导致血管复制性衰老或早衰的关键介质。预防DNA损伤诱导的细胞血管衰老可能是动脉粥样硬化临床治疗的新靶点。